ATTENTION
Effective April 1, 2022, The Merck Access Program for EMEND has been discontinued and will no longer provide reimbursement support for EMEND® (aprepitant).
For inquiries regarding patient assistance, please visit www.merckhelps.com.
Copyright © 2022 Merck & Co., Inc., Kenilworth, NJ, USA and its affiliates. All rights reserved.
US-SUF-00103 03/22